<DOC>
	<DOCNO>NCT01465906</DOCNO>
	<brief_summary>Phrase : IV Indication : dyspnea symptom chronic obstructive pulmonary disease ( COPD ) Objective : evaluate efficacy safety tulobuterol patch combine Tiotropium bromide relieve dyspnea symptom COPD Design : multi-centre randomized parallel blank control study Case number : test group 80 , control group 80 , totally 160 Site number:7 Study period : 2010.9 - 2011.8</brief_summary>
	<brief_title>Efficacy Safety Tulobuterol Patch Combined With Tiotropium Bromide Relieving Dyspnea Symptom Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Tulobuterol</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<criteria>people age 40 80 self ability judgment outpatient diagnose stable COPD accord `` diagnose treatment guideline COPD ( 2007 edition ) '' Respiratory Department Chinese Medical Association PFT value screen phase meet standard follow : FEV1/FVC &lt; 70 % FEV1 % among 30 % 80 % 15 min inhalation 400ug Ventolin ( i.e. , moderate severe COPD patient ) . people use Tiotropium Bromide powder inhalation device people join study voluntarily sign ICF ( Informed Consent Form ) people acute chronic respiratory disease may cause impairment pulmonary function asthma AECOPD （acute exacerbation COPD） people get respiratory failure 1 month study people receive oral corticoid treatment 1 month study people undergo oxygen therapy home respiratory failure people allergic β2 receptor agonist tulobuterol patient Skin diseases atopic dermatitis , appropriate use transdermal patch patient hyperthyroidism , hypertension , heart disease severe arrhythmia , diabetes mellitus , appropriate useβ2 receptor agonist patient undergone pulmonary lobectomy tumor active tuberculosis patient people get acute respiratory tract infection month screen phase allergic rhinitis patient glaucoma patient people disease may cause dysuria prostatic hypertrophy bladder neck occlusion gestation , lactation childbearing age woman n't agree take contraceptive measure study people abnormal live kidney function , people nervous system disease , malignant tumor , neutropenia progressive basic disease . People mental retardation , mentally ill , deafmute uncooperative , correctly describe disease correspond respiratory questionnaire . People allergic atropine derivative ( include tiotropium bromide ipratropium bromide ) , lactose inhalant component . people take part medical clinical trial condition investigator think appropriate study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>